By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Developing a unique class of chemically synthesized medicines based on its proprietary platform11.73M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United Kingdom35.28M100.00%